2019 Media Partners
2018 Launch Sponsor
2018 Associate Sponsors
2018 Technology Sponsors
2018 Supporting Partners
2018 Media Partners
2018 Launch Sponsor
Cambridge Design Partnership is an independent innovation and product development consultancy with offices in Cambridge, UK and Palo Alto, USA. Over the last 20 years, some of the world’s largest companies have trusted us with their most important product development programmes. We provide an integrated and holistic product development capability through our highly qualified team, well equipped development labs and ISO 13485/9001 approved methods. This encompasses research and strategy; design, technology and digital innovation; product development and manufacturing support including short run manufacture.Our experts in engineering, human factors and industrial design are able to take combination products through a full design cycle and submission, to enable you to launch a product that is customer focused and commercially effective. Certified to ISO 13485/9001. Learn more about us at www.cambridge-design.co.uk.
2018 Associate Sponsors
iO life science is a full-service medical device development partner, trusted by established and start-up healthcare innovators. We exist to improve the lives of patients by transforming our clients’ technologies into unique and attractive products with user needs at the core. We accelerate compliance with our agile and ISO13485-approved QMS. Learn more about us at www.iolifescience.com.
2018 Technology Sponsors
Adare Pharmaceutical Technologies is seeking co-development partners who share our vision to improve the lives of patients whose treatment needs are not fully addressed by current medications. We have successfully transformed oral drug formulations and created differentiated patient-centric products. We add valuable IP to commercialized products and products in development. Learn more at www.adarepharma.com.
AdminMed, a leading microneedle array company, is producing and selling several hollow metal microneedle array devices in various sizes. AdminPen allows intradermal injections over large skin area for more effective and painless delivery of immunotherapeutics and all other injectable formulations. AdminStamp allows improving absorption of topical formulations. AdminPatch® microneedle patches enable delivering any APIs transdermally. Learn more about us at www.adminmed.com.
Afecta Pharmaceuticals, Inc. is a patient-centric, physician driven pharmaceutical company focused on identifying and optimizing existing small molecules to treat inflammatory and neurological disorders, especially in women and children The company has already validated its proprietary Artificial Intelligence powered disease/drug targeting platform, PharmetRx™, by discovering and optimizing SPN-810, a drug in development with Supernus (NASDAQ: SUPN). That drug received FDA Fast Track status and is expected to enter the market in 2019. Afecta has now developed a pipeline of “de-risked”, small molecule immune-modulating drug candidates with fast-to-market potential, utilizing the FDA (505(b)(2) pathway. Our current internal drug development programs focus on addressing need unmet needs for inflammatory diseases effecting the; skin, bowel and reproductive tract using several of the drugs we have discovered and novel formulation technologies. Learn more at www.afectapharm.com.
Drug Delivery Experts changes lives through delivery technology by partnering with our clients for the best drug product solutions. We specialize in product development, drug-device combination, and integration with commercial strategy and life cycle plans. Our leadership team has over 200 years of combined experience in pharmaceutical research, development, and commercialization. Learn more about us at www.drugdeliveryexperts.com.
The Aran Lab is a biomedical device lab that focuses on diagnostics and therapeutics at Keck Graduate Institute in Claremont, California. Dr Aran’s research specifically focuses on developing novel bio-microelectromechanical systems (BioMEMS) for research and clinical applications. In particular, she is interested in the integration of multiple engineering disciplines including electrical, mechanical, chemical, and bioengineering to create novel device solutions that address unmet clinical need. Current research topics includes developing microfluidic-based protein extraction module for investigation of age associated biomarkers, functionalized graphene for developing digital lab-on-a-chip (LOC)-based biosensors and developing oral or implantable drug delivery devices to improve delivery of biologics. Learn more at www.aranlab.org.
Phylogica Limited (ASX: PYC) is focused on commercializing its intracellular drug delivery platform. Phylogica has the world’s most structurally diverse source of peptides called Phylomers, which can act as effective drug delivery agents and drug cargoes, penetrating cell walls to reach previously ‘undruggable’ targets across a range of disease types. Learn more about us at www.phylogica.com.
Portal Instruments is developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic diseases. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with significantly less discomfort and without the anxiety of handling needles. Using precise pressure technology, the injection is administered through the skin via a jet the size of a strand of hair, ensuring optimal comfort. Real time tracking and reporting sets a new standard for interactivity between the patient and care teams, monitoring adherence and potentially improving patient outcomes. Visit www.portalinstruments.com.
Simplified and efficient drug administration of large volumes and viscosities can now be delivered with Sorrel Medical, the next generation of wearable drug delivery devices. A true platform solution, with trailblazing technology that is reinventing drug delivery systems, Sorrel delivers more – your way. Visit us at www.sorrelmedical.com.
Starpharma is a world leader in the development of dendrimer products for pharmaceutical, life-science and other applications. Starpharma has unique breadth in its programs (both internal and partnered), which all benefit from its proprietary dendrimer technology. In human health, Starpharma has two core development programs: DEP® dendrimer drug delivery platform (passive and targeted) and the VivaGel® antimicrobial/antiviral portfolio. The DEP®platform provides multiple opportunities to accelerate product development, enhance therapeutic utility and lower development risk of existing products and NCE’s, developing “first-in-class” therapies. For more information, visit www.starpharma.com.
Universal Stabilization Technologies, Inc. is a biopharmaceutical R&D company focused on the development of thermostable biopharmaceuticals and needle-free mucosal and transdermal delivery systems. We partner with companies to deliver superior formulations leveraging our proprietary thermostabilization platform, VitriLife®, to improve the stability, efficacy, and delivery profiles of biopharmaceuticals to levels not otherwise possible with conventional formulation science. Find out more at www.vitrilife.com.
MedinCell is a technology-based pharmaceutical firm which, through purposeful innovation, aims to optimise the efficiency of medical treatments and make them accessible worldwide. MedinCell’s portfolio of products – the most advanced of which are currently at the clinical trial phase 3 – uses BEPO® patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. Based in Montpellier, MedinCell has around 110 employees from over 25 different countries. Learn more at www.medincell.com.
Polar Leasing offers a national fleet of walk-in refrigeration rentals. Units are constructed of seamless fiberglass, ensuring a sanitary environment. Polar Leasing units are sized in 8’x10’ and 8’x20’, with select markets having larger models. Available in temperatures as low as -23°C, units can be configured for temperature mapping and validation. For more information, visit us at www.polarleasing.com.
True Concepts Medical Technologies develops serial Nex-Gen dual syringe technologies for safer, faster, more effective medication delivery as well as a Nex-Gen syringes for medication reconstitution.